Chlorpromazine and Standard of Care in Glioblastoma
Clinical trial NCT05190315 · COMPLETED
Trial details
- NCT number
- NCT05190315
- Sponsor
- Mohammed Milhem
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-28
- Primary completion
- 2023-04-25
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.